Search results
ZYMUTEST Factor IX Antigen
Assay proposed for the measurement of factor IX antigen in research applications.
ZYMUTEST Factor X Antigen
Assay proposed for the measurement of factor X antigen in research applications.
ZYMUTEST Tissue Factor
Assay proposed for the measurement of full length tissue factor in research application.
ZYMUTEST Factor VII Antigen
Assay proposed for the measurement of factor VII antigen in research applications.
ZYMUTEST TAFI (Activatable)
Assay proposed for the measurement of TAFI in research applications.
ZYMUTEST vWF:CBA (Collagen Binding Assay)
Diagnosis of von Willebrand disease (vWD). Assay of vWF:CBA in clinical samples, as a disease marker or as an indicator for cardiovascular diseases.
ZYMUTEST Anti-VIII IgG Mono-Strip
Assay proposed for the measurement of anti-VIII antibodies in research applications.
ZYMUTEST HIA, IgG
Clinical suspicion of HIT during heparin therapy Clinical suspicion of vaccine-induced immune thrombotic thrombocytopenia (VITT) Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.
ZYMUTEST HIA, IgGAM Screening
Assessment of the risk to develop HIT/HITT, in patients treated with heparins (unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT. Clinical suspicion of HIT during heparin therapy.
ZYMUTEST HIA Mono-Strip, IgG
Individual test. Clinical suspicion of HIT during heparin therapy. Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA Mono Strip IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.